The Medicare Prescription Drug Rebate Rule

The Medicare Part D prescription drug benefit provides our nation’s seniors with affordable drug coverage, which is more important now than ever.

The rebate rule clumsily attempts to eliminate the primary tool used by pharmacy benefit managers, or PBMs, to negotiate increased access to affordable prescription drugs with drug manufacturers. The rule would not reduce drug costs: Centers for Medicare and Medicaid Services actuaries and the Congressional Budget Office have said it would significantly increase

 

Medicare Part D premiums and add $170 billion in Part D program costs for taxpayers.

Medicare beneficiaries appreciate the Biden Administration’s decision to delay the prescription drug rebate rule. Congress and the Administration should now permanently repeal the rebate rule and advance real solutions that protect seniors while bringing down the costs of prescription drugs.

Letter to Congress from organizations working to protect seniors and maintain affordable access to prescription drugs

“We believe it is imperative to block implementation of this rule to protect Medicare beneficiaries and taxpayers from unsustainable cost increases.”

READ THE ENTIRE LETTER FROM THE ORGANIZATIONS BELOW

Morning Consult: Congress Should Act Quickly to Permanently Repeal the Rebate Rule

April 12, 2021

While Congress and the Biden administration, as well as stakeholders across the prescription drug supply chain, examine policy options for…

Morning Consult: Congress Should Act Quickly to Permanently Repeal the Rebate Rule

April 12, 2021

While Congress and the Biden administration, as well as stakeholders across the prescription drug supply chain, examine policy options for…

When Medicare Premiums Rise, Beneficiaries In All States Pay More

Medicare Premiums Will Increase an Additional $56 Billion Over 10 Years With Adoption of the HHS “Rebate Rule”

PCMA Launches New Campaign Aimed At Repealing the Medicare Prescription Drug Rebate Rule

READ more

PCMA Launches New Campaign Aimed At Repealing the Medicare Prescription Drug Rebate Rule

READ more

PCMA Launches New Campaign Aimed At Repealing the Medicare Prescription Drug Rebate Rule

READ more

PCMA Launches New Campaign Aimed At Repealing the Medicare Prescription Drug Rebate Rule

READ more

PCMA Launches New Campaign Aimed At Repealing the Medicare Prescription Drug Rebate Rule

READ more

PCMA Launches New Campaign Aimed At Repealing the Medicare Prescription Drug Rebate Rule

READ more

PCMA Launches New Campaign Aimed At Repealing the Medicare Prescription Drug Rebate Rule

READ more

PCMA Launches New Campaign Aimed At Repealing the Medicare Prescription Drug Rebate Rule

READ more

PCMA Launches New Campaign Aimed At Repealing the Medicare Prescription Drug Rebate Rule

READ more

PCMA Launches New Campaign Aimed At Repealing the Medicare Prescription Drug Rebate Rule

READ more

PCMA Launches New Campaign Aimed At Repealing the Medicare Prescription Drug Rebate Rule

READ more

PCMA Launches New Campaign Aimed At Repealing the Medicare Prescription Drug Rebate Rule

READ more

PCMA Launches New Campaign Aimed At Repealing the Medicare Prescription Drug Rebate Rule

READ more

PCMA Launches New Campaign Aimed At Repealing the Medicare Prescription Drug Rebate Rule

READ more

PCMA Launches New Campaign Aimed At Repealing the Medicare Prescription Drug Rebate Rule

READ more

INFOGRAPHICS

Medicare Part D Population Highlights PBM

PBMs Save Employers & Patients $100 Billion Per Year on Prescription Drug Costs

Pbms Save Employers & Patients $625 Per Enrollee Per Year On Prescription Drug Costs

INFOGRAPHICS

“Simply trying to eliminate rebating without any other steps threatens to drive up drug prices overall…Rebates are a key mechanism that insurers use to try to reduce net drug prices.”

– Aaron Kesselheim, Associate Professor of Medicine, Harvard Medical School

(Read more quotes: Coalition for Affordable Prescription Drugs)